Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy

Cite this paper

@inproceedings{Machiels2016RandomizedPI, title={Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy}, author={Jean-Pascal Machiels and Aline G Van Maanen and Jean-Marie Vandenbulcke and Bertrand Filleul and Emmanuel Seront and Stephanie L Henry and Lionel D’hondt and Christophe Lonchay and St{\'e}phane Holbrechts and Petra Boegner and Dany Broh{\'e}e and Didier Dequanter and Ingrid Louviaux and Brieuc Sautois and Nicolas Whenham and Guy Berchem and Brigitte Vanderschueren and Christel Fontaine and Sandra Schmitz and Aline Gillain and Joelle M Schoonjans and Sylvie Rottey}, booktitle={The oncologist}, year={2016} }